v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash Flows from Operating Activities:    
Net loss $ (3,179,278) $ (4,446,184)
Reconciliation of net loss to net cash used in operating activities:    
Stock-based compensation 178,422 379,144
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 240,697 (357,576)
Other receivables (7,900) (112,062)
Related party payable 1,001,229 (1,299,173)
Accounts payable and accrued expenses 614,301 336,114
Deferred grant income (251,663)  
Net cash used in operating activities (1,404,192) (5,499,737)
Cash Flows from Financing Activities:    
Proceeds from exercise of warrants and stock options   505
Net cash provided by financing activities   505
Net decrease in cash, cash equivalents, and restricted cash (1,404,192) (5,499,232)
Cash, cash equivalents, and restricted cash at beginning of the period 17,042,847 19,192,440
Cash, cash equivalents, and restricted cash at end of the period $ 15,638,655 $ 13,693,208